Home / Escitalopram / Canada
CA ATC N06AB10 · updated 2 Nov 2026
Escitalopram shortage in Canada
Is there an Escitalopram shortage in Canada?
Yes. As of 2 Nov 2026, 4 Escitalopram products are reported short in Canada, the first since 17 Jun 2026. The company estimate for the return is 10 Dec 2026 (latest 8 Jan 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-ESCITALOPRAM (1000) | TEVA CANADA LIMITED | 17 Jun 2026 | 10 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ESCITALOPRAM (1000) | SANIS HEALTH INC | 5 Aug 2026 | 8 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACH-ESCITALOPRAM (500) | ACCORD HEALTHCARE INC | 15 Oct 2026 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | ESCITALOPRAM (1000) anticipated | SANIS HEALTH INC | 13 Nov 2026 | 8 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.